Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Japan Regulatory News (SJG)

Share Price Information for Schroder Japan (SJG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.00
Bid: 253.00
Ask: 258.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.976%)
Open: 257.00
High: 0.00
Low: 0.00
Prev. Close: 257.00
SJG Live PriceLast checked at -
Schroder Japan Growth is an Investment Trust

To achieve capital growth from an actively managed portfolio principally comprising securities listed on the Japanese stock markets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

17 Apr 2020 07:00

RNS Number : 9497J
SchroderJapan Growth Fund PLC
17 April 2020
 

17 April 2020

Half Year Report

 

Schroder Japan Growth Fund plc (the "Company") hereby submits its Half Year Report for the period ended 31 January 2020 as required by the UK Listing Authority's Disclosure Guidance and Transparency Rule 4.2.

 

The Half Year Report is also being published in hard copy format and an electronic copy of that document will shortly be available to download from the Company's website www.schroders.co.uk/japangrowth. Please click on the following link to view the document:

 

http://www.rns-pdf.londonstockexchange.com/rns/9497J_1-2020-4-16.pdf

 

The Company has submitted a pdf of the hard copy format of its Half Year Report to the National Storage Mechanism. It will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Enquiries:

 

Benjamin Hanley

Schroder Investment Management Limited

Tel: 020 7658 3847

 

 

 

 

Half Year Report and Accounts for the six months ended 31 January 2020

 

Interim Management Report - Chairman's Statement

 

Performance

 

During the six-month period to 31 January 2020 the net asset value ("NAV") and share price total returns in sterling were 1.8% and 2.3% respectively. This compares to a Benchmark total return of 1.3%.

 

Since the end of January, global markets have experienced sharp drops as a result of COVID-19, and as at 15 April 2020, the Company's published NAV had dropped to 189.53p per share and the Company's share price had dropped to 163.0p per share.

 

Further performance details are set out in the Manager's Review on page 4.

 

Term loan and revolving credit facility

 

The Company has in place a 6 billion yen fixed term loan with Sumitomo Mitsui Banking Corporation Europe Limited ("SMBC"). This term loan is in place until January 2022. In addition, the Company has a 2 billion yen revolving credit facility, also with SMBC. The Company intends to renew this in May 2020.

 

Board refreshment

 

As announced on 31 March 2020, Richard Greer retired from the board after serving for 10 years. The board is grateful for his counsel and contributions during his tenure. As previously announced, and as part of the board's ongoing refreshment, Angus Macpherson joined as a non-executive director on 1 February 2020.

 

Outlook

 

Almost everything that happened in the six months under review has since been dwarfed by the reaction to the coronavirus pandemic. So far Japan is not in as severe a lockdown as in the UK, but companies have suffered from China's problems as supply chains are so interlinked, and stock market sentiment has inevitably been as shocked as elsewhere. The most obvious impact - beyond the human cost - has been a fall in the Company's net asset value of 13.2% since the end of January (as at 15 April), with even a fall of that magnitude offset partly by the decline in sterling relative to the yen.

 

It is difficult to predict how soon this situation will be resolved. I am also conscious that our Manager is facing investment judgements in a context that is relatively novel. However, our presumption is that the holdings in the portfolio - chosen to a large extent for the quality of the management and franchises - will emerge from this with even stronger market positions. We also expect the current market volatility to produce new buying opportunities.

 

It would be reassuring to see evidence that companies' and governments' reactions to the challenge are working, but in the meantime the Company's share price is back to the levels of 2015-16. While corporate profits in Japan will be severely impacted in the short term, any future recovery would make most of the shares in the portfolio look very appealing.

 

Anja Balfour

Chairman

16 April 2020

 

Interim Management Report - Manager's Review

 

Market background

 

The Japanese market was strong for most of the period under review, recording a total return of 8.9%. The yen/sterling exchange rate was volatile, especially from July to October, driven primarily by the UK's domestic political agenda. Across the period however, there was a significant net weakening of the yen, which restricted the total market return in sterling to just 1.3% (Source: Morningstar, 31 January 2020).

 

Sentiment towards Japanese equites generally fluctuated in line with geopolitical tensions but was ultimately helped by signs of some easing in relations between the US and China and expectations for the signing of a Phase 1 trade agreement. Foreigners returned as net buyers of Japanese equities from September onwards, which also influenced the type of shares being sought and sector performance. In reaction to the market strength, the Bank of Japan stepped back from its ongoing ETF purchases in the fourth quarter of 2019 and therefore undershot its own target for the calendar year.

 

Japan's economic data continued to show a significant divergence between the strength in service sectors and the weakness in manufacturing. There were also signs that the long-running trend towards an ever-tighter labour market had finally reached its natural limit as Japan has effectively been operating at full employment for some time.

 

The main domestic events were the Upper House election in July, which was won comfortably by Mr Abe's Liberal Democratic Party, and the increase in consumption tax on 1 October. Some evidence of front-loading of demand ahead of the tax increase was visible, but it is now clear that the subsequent downturn has been greater than consensus expectations, even if allowance is made for the devastating typhoon that hit central Japan in October. In response to the weaker data the government announced a significant supplementary budget, with a particular focus on reconstruction. Investors generally responded positively to this planned fiscal stimulus but towards the end of the period, the COVID-19 outbreak and associated supply-chain disruption raised fears of a second consecutive quarter of economic contraction.

 

At the individual stock level there have recently been several positive examples of corporate activity, which we see as a direct consequence of Japan's drive towards better corporate governance. Some of the contested situations have again focused attention on the rights of minority shareholders and the ways in which value may be realised from within Japanese companies.

 

The Company's NAV rose 1.8% over the six months, ahead of the 1.3% increase in the Benchmark. Although the market environment did not particularly suit the portfolio, there was a positive impact from the gearing in a rising market. There was also a strong positive contribution from TDK, a global supplier of electronic components, which outperformed consistently throughout the period. Conversely, Sankyu, a specialist in logistics and plant engineering, was relatively weak in the last six months, reversing some of the outperformance seen in the previous three years.

 

Activity

 

Several positions were initiated in small cap stocks after some correction in valuations in this area of the market over the previous 12 months. These included Fukushima Galilei, which produces commercial refrigerators, and Trusco Nakayama, an industrial machinery trader, which is improving its logistics operations to benefit from current trends in capital expenditure. Other new holdings were added in Hosokawa Micron, a specialist manufacturer of precision powders with a wide-range of applications across electronic components, lithium batteries, drugs and cosmetics, and Rheon Automatic Machinery, which supplies food production equipment used to automate processes and provide consistent quality. Among larger companies, Taisei was also added to the portfolio. This represents a contrarian view on a stock that has underperformed for more than two years, where we see some signs of a turnaround. We also appreciate the company's progress in increasing shareholder remuneration through both dividends and share buy-backs.

 

These purchases were funded from sales where we felt the stock-specific drivers had weakened, including Sumitomo Electric, a major supplier of cables and automobile wire harnesses, and Mitsubishi Electric, which produces electrical machinery and industrial products. We also sold the position in Nomura Holdings, the parent company of Nomura Securities. Our conviction in this position had gradually been declining as management repeatedly failed to deliver the anticipated improvements, especially in their overseas businesses.

 

There was a significant reduction in the weighting of Japan Tobacco. The company is struggling to regain the market share lost to overseas competitors in recent years, especially in new tobacco products. While we initially felt this problem would be rectified once production problems were ironed out, we increasingly feel there is more of a structural problem.

 

The position in Mitsubishi Tanabe, a pharmaceutical maker, was sold out of the portfolio. Rather unexpectedly, its parent company, Mitsubishi Chemical, which already owned 56% of the shares, announced a full takeover bid for the company in November at a premium of 50% to the previous share price. The stock immediately moved up to that level and, as we saw no possibility for a higher bid, we sold the Company's holding in the market at the take-over bid price.

 

Outlook

 

Although there could be additional downside from a more extended global slowdown, a significant earnings downturn was already priced into Japanese equities by mid-March. Although short-term earnings remain under pressure, market valuations have also adjusted quickly and the prospective PE ratio of 10.2x for 2021 and the Price-to-Book ratio of 0.85x continue to look attractive against Japan's recent ranges, and compared to other developed markets. While we are unsure of the exact path for earnings revisions in 2020, the most important point will be when investors move their forecast horizon to a more normal period in fiscal year 2021. On a relative basis, there should be a greater potential upside for small companies, given their recent sharp correction against large caps.

 

For now however, we need to be aware of persistent volatility around the news flow on COVID-19 and the associated policy responses. In the very near term the most likely impact on sentiment in Japan could come from additional restrictions on domestic travel and activity within Tokyo and the current situation provides multiple reasons for companies to be extremely cautious in their forecasts for the fiscal year just starting.

 

There could be an additional risk for Japan from any persistent yen appreciation, although there has been no evidence of this yet. Despite the current volatility in exchange rates the yen has remained broadly in a range that should have limited incremental impact on corporate earnings.

 

We should also remember that the long-term structural improvements we were seeing in Japan are unlikely to be permanently reversed, even if they seem to be overwhelmed by short-term news flow. Corporate activity continued to surprise positively in the early part of 2020, with individual cases of contested takeovers breaking new ground for Japan in the past few months. We continue to see this as a natural extension of stronger corporate governance and the drive towards better capital allocation that ultimately has the potential to close the valuation gap between Japan and other developed markets.

 

We are particularly interested to see the near-term path for share buybacks, which hit a new record high in March. The strength of Japanese balance sheets provides a competitive advantage for Japan in the current environment and would allow companies to continue to buy back their shares at depressed levels more easily then their global peers. Although we may see some companies cutting dividends this year, we would also expect the aggregate reduction to be less severe in Japan, as was the case in the aftermath of the global financial crisis.

 

Of course, we understand the risk of a more serious economic impact in the near future, especially in Japan, given a high level of risk aversion and the integration with supply chains throughout Asia. Nevertheless, on any long-term time horizon, we should view sharp sell-offs as opportunities to build positions in our highest conviction ideas: the investment process focuses on strong balance sheets, quality management and improving corporate governance, which should mean the companies we own will emerge in even stronger market positions than before.

 

Policy

 

Market dynamics have tended to favour a relatively narrow range of stocks, reflecting global political and macro issues, rather than stock-specific factors that we would normally expect to drive performance. The impact of the COVID-19 outbreak has obviously clouded the short-term outlook but has not led us to change our longer-term views on Japan. Even without any sharp changes in factor leadership from here, we should ultimately expect a return to a more normal environment in which individual stock factors are the primary driver of long-term stock price returns, and the Company is well placed to benefit from this.

 

The Company remains underweight in the Electric Appliance sector, although this is balanced by the overweight positions in specific stocks in the Machinery sector that have the same underlying drivers. The Company is neutrally weighted in financials overall but, within this, we have a strong preference for insurance and leasing companies, while underweighting banks. Net gearing at the end of January 2020 was 11.6%.

 

We continue to expect that the most likely way for Japan's relative undervaluation to be narrowed will be through better corporate governance, rather than any step-change in trend growth. The most pervasive element for change is the stronger pressure being applied to company managements from institutional investors to deliver a higher return on equity and better shareholder remuneration. We expect these factors to have a strong positive influence on the Company.

 

Schroder Investment Management Limited

16 April 2020

 

Interim Management Report

 

Principal risks and uncertainties

 

The principal risks and uncertainties with the Company's business fall into the following risk categories: strategic; investment management; financial and currency; custody; gearing and leverage; accounting, legal and regulatory; and service provider. A detailed explanation of the risks and uncertainties in each of these categories can be found on pages 13 and 14 of the Company's published annual report and accounts for the year ended 31 July 2019. These risks and uncertainties have not materially changed during the six months ended 31 January 2020. However the board has reviewed the risks related to the COVID-19 pandemic and considers it to be an emerging risk. COVID-19 will continue to affect the value of the Company's investments due to the disruption of supply chains and demand for products and services, increased costs and cash flow problems, and changed legal and regulatory requirements for companies. The pandemic has triggered a sharp fall in global stock markets and created uncertainty around future dividend income. The fall in the Company's NAV per share and share price after the balance sheet date has been highlighted as a post balance sheet event in Note 10 to the Accounts on page 15. The board notes the Manager's investment process is unaffected by the COVID-19 pandemic and they continue to focus on long-term company fundamentals and detailed analysis of current and future investments. COVID-19 also affected the Company's service providers, who have implemented business continuity plans and are working almost entirely remotely. The board continues to receive regular reporting on operations from the Company's major service providers and does not anticipate a fall in the level of service.

 

Going concern

 

Having assessed the principal risks and uncertainties, and the other matters discussed in connection with the viability statement as set out on page 15 of the published annual report and accounts for the year ended 31 July 2019, as well as considering the additional risks related to COVID-19, and where appropriate, action taken by the Company's service providers in relation to those risks, detailed above, the directors consider it appropriate to adopt the going concern basis in preparing the accounts.

 

Related party transactions

 

There have been no transactions with related parties that have materially affected the financial position or the performance of the Company during the six months ended 31 January 2020.

 

Directors' responsibility statement

 

The directors confirm that, to the best of their knowledge, this set of condensed financial statements has been prepared in accordance with United Kingdom Generally Accepted Accounting Practice and with the Statement of Recommended Practice, "Financial Statements of Investment Companies and Venture Capital Trusts" issued in November 2014 and updated in October 2019 and that this Interim Management Report includes a fair review of the information required by 4.2.7R and 4.2.8R of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

Income Statement

 

For the six months ended 31 January 2020 (unaudited)

 

 

(Unaudited)

For the six months

ended 31 January 2020

(Unaudited)

For the six months

ended 31 January 2019

(Audited)

For the year

ended 31 July 2019

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gains/(losses) on investmentsheld at fair value through profitor loss

-

84

84

-

(29,062)

(29,062)

-

(13,985)

(13,985)

Net foreign currency gains/(losses)

-

2,624

2,624

-

(958)

(958)

-

(3,751)

(3,751)

Income from investments

4,076

-

4,076

3,726

-

3,726

8,157

-

8,157

Other interest receivable and similar income

4

-

4

4

-

4

7

-

7

Gross return/(loss)

4,080

2,708

6,788

3,730

(30,020)

(26,290)

8,164

(17,736)

(9,572)

Investment management fee

(309)

(721)

(1,030)

(326)

(760)

(1,086)

(642)

(1,497)

(2,139)

Administrative expenses

(318)

-

(318)

(307)

-

(307)

(619)

-

(619)

Net return/(loss) before finance costs and taxation

3,453

1,987

5,440

3,097

(30,780)

(27,683)

6,903

(19,233)

(12,330)

Finance costs

(41)

(96)

(137)

(52)

(120)

(172)

(93)

(217)

(310)

Net return/(loss) on ordinary activities before taxation

3,412

1,891

5,303

3,045

(30,900)

(27,855)

6,810

(19,450)

(12,640)

Taxation on ordinary activities (note 3)

(408)

-

(408)

(373)

-

(373)

(816)

-

(816)

Net return/(loss) on ordinary activities after taxation

3,004

1,891

4,895

2,672

(30,900)

(28,228)

5,994

(19,450)

(13,456)

Return/(loss) per share (note 4)

2.40p

1.51p

3.91p

2.14p

(24.72)p

(22.58)p

4.79p

(15.56)p

(10.77)p

 

The "Total" column of this statement is the profit and loss account of the Company. The "Revenue" and "Capital" columns represent supplementary information prepared under guidance issued by The Association of Investment Companies. The Company has no other items of other comprehensive income and therefore the net return on ordinary activities after taxation is also the total comprehensive income for the period.

 

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

Statement of Changes in Equity

 

For the six months ended 31 January 2020 (unaudited)

 

 

Called-up

share

capital

£'000

Share

premium

£'000

Warrant

exercise

reserve

£'000

Share

purchase

reserve

£'000

Capital

reserves

£'000

Revenue

reserve

£'000

Total

£'000

At 31 July 2019

12,501

7

3

97,205

157,258

6,838

273,812

Net return on ordinary activities

-

-

-

-

1,891

3,004

4,895

Dividend paid in the period (note 5)

-

-

-

-

-

(5,875)

(5,875)

At 31 January 2020

12,501

7

3

97,205

159,149

3,967

272,832

 

For the six months ended 31 January 2019 (unaudited)

 

 

Called-up

share

capital

£'000

Share

premium

£'000

Warrant

exercise

reserve

£'000

Share

purchase

reserve

£'000

Capital

reserves

£'000

Revenue

reserve

£'000

Total

£'000

At 31 July 2018

12,501

7

3

97,205

176,708

5,844

292,268

Net (loss)/return on ordinary activities

-

-

-

-

(30,900)

2,672

(28,228)

Dividend paid in the period (note 5)

-

-

-

-

-

(5,000)

(5,000)

At 31 January 2019

12,501

7

3

97,205

145,808

3,516

259,040

 

For the year ended 31 July 2019 (audited)

 

 

Called-up

share

capital

£'000

Share

premium

£'000

Warrant

exercise

reserve

£'000

Share

purchase

reserve

£'000

Capital

reserves

£'000

Revenue

reserve

£'000

Total

£'000

At 31 July 2018

12,501

7

3

97,205

176,708

5,844

292,268

Net (loss)/return on ordinary activities

-

-

-

-

(19,450)

5,994

(13,456)

Dividend paid in the year (note 5)

-

-

-

-

-

(5,000)

(5,000)

At 31 July 2019

12,501

7

3

97,205

157,258

6,838

273,812

 

Statement of Financial Position

 

at 31 January 2020

 

 

(Unaudited)

At 31 January

2020

£'000

(Unaudited)

At 31 January

2019

£'000

(Audited)

At 31 July

2019

£'000

Fixed assets

 

 

 

Investments held at fair value through profit or loss

303,943

295,036

307,753

Current assets

 

 

 

Debtors

1,617

1,895

1,108

Cash at bank and in hand

10,457

5,921

11,414

 

12,074

7,816

12,522

Current liabilities

 

 

 

Creditors: amounts falling due within one year

(1,190)

(1,901)

(1,331)

Net current assets

10,884

5,915

11,191

Total assets less current liabilities

314,827

300,951

318,944

Creditors: amounts falling due after more than one year (note 6)

(41,995)

(41,911)

(45,132)

Net assets

272,832

259,040

273,812

Capital and reserves

 

 

 

Called-up share capital (note 7)

12,501

12,501

12,501

Share premium

7

7

7

Warrant exercise reserve

3

3

3

Share purchase reserve

97,205

97,205

97,205

Capital reserves

159,149

145,808

157,258

Revenue reserve

3,967

3,516

6,838

Total equity shareholders' funds

272,832

259,040

273,812

Net asset value per share (note 8)

218.25p

207.22p

219.04p

 

Notes to the Accounts

 

1. Financial statements

 

The information contained within the accounts in this half year report has not been audited or reviewed by the Company's independent auditor.

 

The figures and financial information for the year ended 31 July 2019 are extracted from the latest published accounts of the Company and do not constitute statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the report of the auditor which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

 

2. Accounting policies

 

Basis of accounting

 

The accounts have been prepared in accordance with United Kingdom Generally Accepted Accounting Practice and with the Statement of Recommend Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued by the Association of Investment Companies in November 2014 and updated in October 2019.

 

All of the Company's operations are of a continuing nature.

 

The accounting policies applied to these accounts are consistent with those applied in the accounts for the year ended 31 July 2019.

 

3. Taxation on ordinary activities

 

The Company's effective corporation tax rate is nil, as deductible expenses exceed taxable income. The tax charge comprises irrecoverable overseas withholding tax.

 

4. Return/(loss) per share

 

 

(Unaudited)

Six months

ended

31 January

2020

£'000

(Unaudited)

Six months

ended

31 January

2019

£'000

(Audited)

Year ended

31 July

2019

£'000

Revenue return

3,004

2,672

5,994

Capital return/(loss)

1,891

(30,900)

(19,450)

Total return/(loss)

4,895

(28,228)

(13,456)

Weighted average number of shares in issue duringthe period

125,008,200

125,008,200

125,008,200

Revenue return per share

2.40p

2.14p

4.79p

Capital return/(loss) per share

1.51p

(24.72)p

(15.56)p

Total return/(loss) per share

3.91p

(22.58)p

(10.77)p

 

5. Dividends paid

 

 

(Unaudited)

Six months

ended

31 January

2020

£'000

(Unaudited)

Six months

ended

31 January

2019

£'000

(Audited)

Year ended

31 July

2019

£'000

2019 final dividend paid of 4.7p (2018: 4.0p)

5,875

5,000

5,000

 

No interim dividend has been declared in respect of the year ended 31 July 2020 (2019: nil).

 

6. Creditors: amount falling due after more than one year

 

 

(Unaudited)

Six months

ended

31 January

2020

£'000

(Unaudited)

Six months

ended

31 January

2019

£'000

(Audited)

Year ended

31 July

2019

£'000

Bank Loan

41,995

41,911

45,132

 

The bank loan is a yen 6.0 billion three-year term loan from Sumitomo Mitsui banking Corporation, expiring in January 2022 and carrying a fixed interest rate of 0.64% per annum.

 

7. Called-up share capital

 

 

(Unaudited)

Six months

ended

31 January

2020

£'000

(Unaudited)

Six months

ended

31 January

2019

£'000

(Audited)

Year ended

31 July

2019

£'000

Ordinary shares allotted, called up and fully paid: 125,008,200 ordinary shares of 10p each

12,501

12,501

12,501

 

8. Net asset value per share

 

Net asset value per share is calculated by dividing shareholders' funds by the number of shares in issue of 125,008,200 (31 January 2019 and 31 July 2019: same).

 

9. Financial instruments measured at fair value

 

The Company's financial instruments that are held at fair value comprise its investment portfolio. At 31 January 2020, all investments in the Company's portfolio were categorised as Level 1 in accordance with the criteria set out in paragraph 34.22 (amended) of FRS 102. That is, they are all valued using unadjusted quoted prices in active markets for identical assets (31 January 2019 and 31 July 2019: same).

 

10. Events after the interim period that have not been reflected in the financial statements for the interim period

 

The occurrence of the coronavirus pandemic after the balance sheet date has triggered a sharp fall in global stock markets. At 15 April 2020, the latest practicable date, the Company's published NAV per share had fallen to 189.53p, and the share price to 163.0p.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BLGDSSSBDGGL
Date   Source Headline
2nd May 20245:11 pmRNSTransaction in Own Shares
2nd May 202410:48 amRNSNet Asset Value(s)
1st May 20245:17 pmRNSTransaction in Own Shares
1st May 20243:07 pmRNSPortfolio Update
1st May 202410:42 amRNSNet Asset Value(s)
30th Apr 20245:15 pmRNSTotal Voting Rights
30th Apr 202411:35 amRNSTransaction in Own Shares
30th Apr 202410:22 amRNSNet Asset Value(s)
29th Apr 202410:25 amRNSNet Asset Value(s)
26th Apr 20245:20 pmRNSTransaction in Own Shares
26th Apr 202410:48 amRNSNet Asset Value(s)
25th Apr 202410:47 amRNSNet Asset Value(s)
24th Apr 202410:29 amRNSNet Asset Value(s)
23rd Apr 202411:11 amRNSNet Asset Value(s)
22nd Apr 202410:38 amRNSNet Asset Value(s)
22nd Apr 20247:00 amRNSResults analysis from Kepler Trust Intelligence
19th Apr 202410:18 amRNSNet Asset Value(s)
18th Apr 202410:19 amRNSNet Asset Value(s)
17th Apr 202410:39 amRNSNet Asset Value(s)
17th Apr 20247:00 amRNSHalf-year Report
16th Apr 202410:37 amRNSNet Asset Value(s)
15th Apr 20244:14 pmRNSPortfolio Update
15th Apr 202411:42 amRNSNet Asset Value(s)
12th Apr 202411:07 amRNSNet Asset Value(s)
11th Apr 202410:37 amRNSNet Asset Value(s)
10th Apr 202410:28 amRNSNet Asset Value(s)
9th Apr 202411:08 amRNSNet Asset Value(s)
8th Apr 202411:23 amRNSNet Asset Value(s)
5th Apr 202410:28 amRNSNet Asset Value(s)
4th Apr 202411:04 amRNSNet Asset Value(s)
3rd Apr 202410:38 amRNSNet Asset Value(s)
2nd Apr 20241:51 pmRNSHolding(s) in Company
2nd Apr 202411:13 amRNSNet Asset Value(s)
28th Mar 20245:08 pmRNSTotal Voting Rights
28th Mar 202411:19 amRNSNet Asset Value(s)
27th Mar 202411:00 amRNSNet Asset Value(s)
26th Mar 202411:31 amRNSNet Asset Value(s)
25th Mar 202411:25 amRNSNet Asset Value(s)
22nd Mar 20244:59 pmRNSHolding(s) in Company
22nd Mar 202410:35 amRNSNet Asset Value(s)
21st Mar 202410:24 amRNSNet Asset Value(s)
20th Mar 202410:37 amRNSNet Asset Value(s)
19th Mar 202410:45 amRNSNet Asset Value(s)
18th Mar 202410:50 amRNSNet Asset Value(s)
15th Mar 202410:37 amRNSNet Asset Value(s)
14th Mar 202410:40 amRNSNet Asset Value(s)
13th Mar 20245:18 pmRNSDirector Declaration
13th Mar 202410:29 amRNSNet Asset Value(s)
12th Mar 202411:04 amRNSNet Asset Value(s)
11th Mar 20245:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.